ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,527.20
      1.07%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      -2.20%
      Bitcoin
      67,918.17
      3.24%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Alzamend Neuro Inc (ALZN)

      7. Alzamend Neuro Inc (ALZN) Financials

      Alzamend Neuro Inc

      Alzamend Neuro Inc (ALZN)

      NASDAQ
      3.81
      -0.08
      (-2.06%)
      At close: July 26 4:00PM
      Delayed by 15 minutes
      3.81
      0.00
      ( 0.00% )
      After Hours: 4:00PM
      Delayed by 15 minutes

      Alzamend Neuro Inc Financial Summary

      The current ALZN market cap is 3.04M. The company's latest EPS is USD -18.6400 and P/E is -0.20.

      Income Statement

      Annual Quarterly
      Quarter End Jan 2023Apr 2023Jul 2023Oct 2023Jan 2024
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -5.42M-3.3M-3.53M-2.9M-2.66M
      Net Income -5.43M-3.31M-3.53M-2.91M-2.66M
      Year End April 29 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0000
      Operating Income -3.17M-4.95M-12.32M-14.87M
      Net Income -3.17M-5.05M-12.36M-14.88M

      Balance Sheet

      Annual Quarterly
      Quarter End Jan 2023Apr 2023Jul 2023Oct 2023Jan 2024
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 8.5M5.92M2.63M984k783k
      Total Liabilities 2.64M2.87M2.74M3.67M4.57M
      Total Equity 5.86M3.05M-113k-2.68M-4.26M
      Year End April 29 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.81M2.91M14.52M5.92M
      Total Liabilities 992k899k1.17M2.87M
      Total Equity 822k2.01M13.35M3.05M

      Cash Flow

      Annual Quarterly
      Quarter End Jan 2023Apr 2023Jul 2023Oct 2023Jan 2024
      USD ($)USD ($)USD ($)USD ($)
      Operating -6.69M-8.92M-3.3M-4.81M-6.84M
      Investing N/A N/A -147k-147k-147k
      Financing N/A N/A N/A 18k2.13M
      Year End April 29 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Operating -2.15M-2.71M-6.61M-8.92M
      Investing 105k101k-106k N/A
      Financing 2.29M4.45M18.85M N/A

      Stats and Ratios

      Market Cap 3.04M
      Price to Earnings Ratio -0.20
      Price to Sales Ratio 0
      Price to Cash Ratio 0.59
      Price to Book Ratio 1
      Dividend Yield -

      Share Statistics

      Shares Outstanding 798.18k
      Average Volume (1 week) 25.07k
      Average Volume (1 Month) 62.81k
      52 Week Change -43.56%
      52 Week High 7.341
      52 Week Low 0.3691
      Spread (Intraday) 0.09 (2.31%)

      Company Info

      Company Name Alzamend Neuro Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.alzamend.com
      Industry pharmaceutical preparations (2834)